TITLE

Teriparatide (hPTH-[1-34])

AUTHOR(S)
Ashworth, L.E.
PUB. DATE
March 2002
SOURCE
Formulary;Mar2002, Vol. 37 Issue 3, p129
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Examines the efficacy of teriparatide (hPTH-[1-34]) in treating osteoporosis. Pharmacological properties of teriparatide; Increase in the total-body bone mass density; Adverse effects of the drug.
ACCESSION #
6351797

 

Related Articles

  • New options in treating osteoporosis. LoBuono, Charlotte // Drug Topics;5/5/2003 Supplement, Vol. 147 Issue 9, p9S 

    Focuses on the alternative option in the treatment of osteoporosis called teriparatide, a recombinant form of human parathyroid hormone. Recommended administration; Most common adverse effects; Other therapies for osteoporosis.

  • New Treatment Builds Bone 'Dramatically.'.  // Arthritis Today;Nov/Dec2001, Vol. 15 Issue 6, p24 

    Presents the results of a study on the use of a synthetic human parathyroid hormone fragment in treating osteoporosis. Methods used; Significance of taking parathyroid hormone to increases in spinal bone density; Benefits in treating several types of osteoporosis.

  • Combination Treatments Show No Increase in BMD.  // Professional Safety;Dec2003, Vol. 48 Issue 12, p61 

    Discusses studies indicating that the combination treatment of parathyroid hormone with alendronate provides no significant improvement in bone mineral density, a procedure to cure osteoporosis. Benefits of the studies for osteoporosis patients; Clinical guidance offered by the findings to...

  • bmj updates.  // BMJ: British Medical Journal (International Edition);8/12/2006, Vol. 333 Issue 7563, preceding p311 

    The article provides a summary of the article "Parathyroid hormone for the treatment of osteoporosis: a systematic review," by A. Cranney, et al. The study evaluated the use of parathyroid hormone as a treatment for osteoporosis in women. The research found that the use of parathyroid hormone...

  • Alternate Treatment for Osteoporosis. Elliott, William T. // Clinical Oncology Alert;Apr2007 Pharmacology Watch, p2 

    The article presents findings of a study on the efficacy of recombinant human parathyroid hormone (PTH), a bone forming agent, as an alternative treatment for osteoporosis. According to the study, PTH significantly reduced the risk for new or worsened vertebral fractures, with the varied...

  • Efficiency of 48h vs. 24h Injection of Parathyroid Hormone for Amelioration of Osteopenic Spine Properties in Male Rats. Komrakova, Marina; Stuermer, Ewa K.; Sturm, Armin; Schmelz, Ulrich; Tezval, Mohammad; Stuermer, Klaus M.; Sehmisch, Stephan // Open Bone Journal;2012, Vol. 4, p20 

    Daily application of parathyroid hormone (PTH 1-34) is used for treatment of osteoporosis. It was investigated whether orchiectomy-induced osteoporotic changes in spine can be ameliorated by every 48h administration of PTH in aged male rats. Eight-month-old male Sprague-Dawley rats were sham...

  • Review: Parathyroid hormone increases lumbar spine bone mineral density and decreases vertebral fractures in osteoporosis. Cummings, Steven R. // ACP Journal Club;Jul/Aug2003, Vol. 139 Issue 1, p11 

    Provides information on the study on parathyroid hormone (PTH) for treatment of osteoporosis. Types of osteoporosis; Details on PTH treatment; Need for determining the effect of combining antiresorptives and PTH.

  • Emerging therapeutic opportunities for skeletal restoration. Kawai, Masanobu; Mödder, Ulrike I.; Khosla, Sundeep; Rosen, Clifford J.; Mödder, Ulrike I // Nature Reviews Drug Discovery;Feb2011, Vol. 10 Issue 2, p141 

    Osteoporosis, a syndrome characterized by thin bones and fractures, has become more prevalent in both women and men. Established therapies for treating this disorder consist primarily of drugs that prevent bone loss, such as the bisphosphonates and selective oestrogen receptor modulators....

  • A Guide to Osteoporosis Medications.  // Healthy Years;Mar2014, Vol. 11 Issue 3, p6 

    The article offers a guide to several medications for osteoporosis. A study published online in the "New England Journal of Medicine" on January 1, 2014 suggests that a new drug called romosozumab may offer hope for the treatment of osteoporosis. Other current treatment options for disease...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics